(Q48262909)

English

Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.

scientific article published in September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Bifidobacterium lactis

object named as

Bifidobacterium lactis

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

author name string

Seung Won Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

Hee Man Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

Kyoung Min Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

Sun-Ah Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

Sung-Kyu Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

Min Ji An

6

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

Jae Jun Park

7

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

Sang Kil Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

Tae Il Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

Won Ho Kim

10

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

16

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

9

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

1514-1525

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

Colorectal cancer in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Cancer risk in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

NF-kappaB regulation in the immune system

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Molecular aspects of intestinal epithelial cell-bacterial interactions that determine the development of intestinal inflammation

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

NF-kappaB signaling proteins as therapeutic targets for inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

NF-kappaB in cancer: from innocent bystander to major culprit

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB(EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

The role of prostaglandins and other eicosanoids in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Bifidobacterium Lactis sp. 420 up-regulates cyclooxygenase (Cox)-1 and down-regulates Cox-2 gene expression in a Caco-2 cell culture model.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

The expression of COX2 protein induced by Lactobacillus rhamnosus GG, endotoxin and lipoteichoic acid in T84 epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21262

21 January 2018

Identifiers

10.1002/IBD.21262

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20310012

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48262909&oldid=2110055986"